Stock Details
ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 168.30$. Average daily volumn in 3 months 2.18M. Market cap 83.88B

Stock symbol : ZTS. Exchange : NYSE. Currency : USD
Lastest price : 178.23$. Total volume : 191.70k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Zoetis Inc. (ZTS)
Last Price

Previous Close174.25
Day Range174.40-178.29
Bid175.75 x 1.1k
Ask176.04 x 800
Average Volume2.18M
Market Cap83.88B
52 Week Range154.18-249.27
Trailing P/E40.88
Foward P/E30.89
Dividend (Yield %)0.75%
Ex-Dividend Date2022-07-20

Financial Details

According to Zoetis Inc.'s financial reports the company's revenue in 2021 were 7.78B an increase( +16.67%) over the years 2020 revenue that were of 6.67B. In 2021 the company's total earnings were 2.04B while total earnings in 2020 were 1.64B( +100%).

Loading ...


Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or ... induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Market Cap:
Total Assets:
Total Cash:

News about "Zoetis Inc."


Transcend Capital Advisors LLC Boosts Holdings in Zoetis Inc. (NYSE:ZTS)

Source from : Defense World - 1 days ago

Transcend Capital Advisors LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS โ€“ Get Rating) by 8.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange ...See details»


Zoetis Inc. (NYSE:ZTS) Receives Average Recommendation of โ€œModerate Buyโ€ from Brokerages

Source from : Defense World - 2 days ago

Zoetis Inc. (NYSE:ZTS โ€“ Get Rating) has earned an average recommendation of โ€œModerate Buyโ€ from the ten brokerages that are covering the company, reports. Two investment analysts have ...See details»

Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results

Source from : Associated Press - 6 days ago

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial ...See details»


Peoples Financial Services CORP. Buys Shares of 700 Zoetis Inc. (NYSE:ZTS)

Source from : ETF Daily News - 9 days ago

Peoples Financial Services CORP. bought a new stake in shares of Zoetis Inc. (NYSE:ZTS โ€“ Get Rating) during the 1st quarter, according to the company in its most recent 13F filing with the Securities ...See details»

Zoetis Inc.: Zoetis Sees Strong Companion Animal Growth to Offset Softness in Production Animals

Source from : Yahoo Finance - 7 days ago

Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an ...See details»

Zoetis Inc.: Zoetis Sees Companion Animal Strength in Q1 Despite Pressure in Livestock Segment; FVE Unchanged

Source from : Yahoo Finance - 12 days ago

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle ...See details»

Zoetis Inc Class A - Stock Quote ZOE

Source from : Morningstar%2c Inc. - 7 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»

Zoetis completes Basepaws acquisition

Source from : NJBIZ - 13 days ago

Parsippany-based Zoetis Inc. announced June 22 it completed its previously announced acquisition of Basepaws, a privately held pet care genetics company headquartered in Los Angeles. Financial ...See details»

Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions

Source from : The Globe and Mail - 14 days ago

Zoetis Inc. (NYSE:ZTS) today announced the completion of its acquisition of Basepaws, a privately held petcare genetics company, which provides pet owners with genetic tests, analytics and early ...See details»


MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $264,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Source from : ETF Daily News - 11 days ago

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH decreased its stake in Zoetis Inc. (NYSE:ZTS โ€“ Get Rating) by 40.5% in the 1st quarter, according to the company in its most recent disclosure with the ...See details»

Veterinary Oncology Market See Incredible Growth 2022-2028 | Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH

Source from : Digital Journal - 8 days ago

Veterinary Oncology Market Research Report offers you with thorough and reliable analysis to help you boost your market position. It gives you the most recent updates and significant insights ...See details»

XLV, CVS, CI, ZTS: Large Outflows Detected at ETF

Source from : Nasdaq - 9 days ago

Among the largest underlying components of XLV, in trading today CVS Health Corporation (Symbol: CVS) is up about 0.1%, Cigna Corp (Symbol: CI) is trading flat, and Zoetis Inc (Symbol: ZTS ...See details»

Global Veterinary Diagnostics Market Report to 2029 - Featuring Thermo Fisher Scientific, Zoetis and Neogen Among Others

Source from : Yahoo - 6 days ago

DUBLIN, June 30, 2022 /PRNewswire/ -- The "Veterinary Diagnostics Market by Product, Technology, Animal Type, End User - Global Forecast to 2029" report has been added to's ...See details»

Equine Pharmaceuticals and Supplements Market Size, Share, Growth, Top Manufacture, Regional Analysis and Global Forecast to 2022-2029

Source from : MarketWatch - 2 days ago

Global "Equine Pharmaceuticals and Supplements Market" research report covers the entire scenario of the worldwide ...See details»